OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SMSMED60

Scandinavian Medical Solutions A/S

Advanced Medical Equipment & TechnologyVerified

Scandinavian Medical Solutions A/S has a debt-to-equity ratio of 0.77 and a current ratio of 1.56, indicating moderate leverage and acceptable short-term liquidity. However, the company reported negative operating cash flow of -13.41 million DKK and free cash flow of -12.06 million DKK, suggesting ongoing cash flow challenges. The company's return on equity is 0.03%, and return on assets is 0.01%, both significantly below typical thresholds for profitable operations in the healthcare equipment sector. The company's profitability is weak, with a net income of 26,000 DKK and an operating income of 1.79 million DKK. These figures are far below the median for the Advanced Medical Equipment & Technology industry, which typically sees higher returns due to the capital-intensive nature of the sector. Gross profit of 56.75 million DKK is also modest relative to revenue of 245.44 million DKK, indicating low gross margins and potential pricing or cost control issues. The company operates as a single business segment, with no disclosed geographic diversification. All revenue is attributed to its core business of providing used diagnostic imaging equipment and related services. This lack of diversification increases exposure to regional economic or regulatory shifts, particularly in the healthcare sector. Looking ahead, the company is expected to face continued financial pressure. The outlook for the current fiscal year shows a negative operating cash flow and free cash flow, with no clear indication of improvement in the next fiscal year. The capital expenditure of -20.81 million DKK suggests ongoing investment in equipment, but without a corresponding increase in revenue or profitability, this may not be sustainable. The risk assessment highlights liquidity as a medium concern, with the company's net cash position being negative after accounting for total debt. The dilution risk is currently low, but the company's weak financial performance and negative cash flows could lead to future equity issuances, which would dilute existing shareholders. No recent filings or transcripts have been provided that indicate significant changes in the company's operations or strategy. The company's risk profile is further complicated by the healthcare sector's sensitivity to regulatory changes and reimbursement policies. As a provider of used medical equipment, Scandinavian Medical Solutions A/S may be affected by shifts in healthcare spending or changes in the demand for second-hand medical devices.

30-day price · SMSMED(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyScandinavian Medical Solutions A/S
TickerSMSMED.CO
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. Scandinavian Medical Solutions A/S provides used diagnostic imaging equipment and related services, including MRI devices, ultrasound scanners, and linear accelerators, to healthcare organizations, enabling cost-effective healthcare delivery.

Classification. Scandinavian Medical Solutions A/S is classified under the Healthcare economic sector, Healthcare Services & Equipment business sector, and Advanced Medical Equipment & Technology industry, with a confidence level of 0.92.

Scandinavian Medical Solutions A/S has a debt-to-equity ratio of 0.77 and a current ratio of 1.56, indicating moderate leverage and acceptable short-term liquidity. However, the company reported negative operating cash flow of -13.41 million DKK and free cash flow of -12.06 million DKK, suggesting ongoing cash flow challenges. The company's return on equity is 0.03%, and return on assets is 0.01%, both significantly below typical thresholds for profitable operations in the healthcare equipment sector. The company's profitability is weak, with a net income of 26,000 DKK and an operating income of 1.79 million DKK. These figures are far below the median for the Advanced Medical Equipment & Technology industry, which typically sees higher returns due to the capital-intensive nature of the sector. Gross profit of 56.75 million DKK is also modest relative to revenue of 245.44 million DKK, indicating low gross margins and potential pricing or cost control issues. The company operates as a single business segment, with no disclosed geographic diversification. All revenue is attributed to its core business of providing used diagnostic imaging equipment and related services. This lack of diversification increases exposure to regional economic or regulatory shifts, particularly in the healthcare sector. Looking ahead, the company is expected to face continued financial pressure. The outlook for the current fiscal year shows a negative operating cash flow and free cash flow, with no clear indication of improvement in the next fiscal year. The capital expenditure of -20.81 million DKK suggests ongoing investment in equipment, but without a corresponding increase in revenue or profitability, this may not be sustainable. The risk assessment highlights liquidity as a medium concern, with the company's net cash position being negative after accounting for total debt. The dilution risk is currently low, but the company's weak financial performance and negative cash flows could lead to future equity issuances, which would dilute existing shareholders. No recent filings or transcripts have been provided that indicate significant changes in the company's operations or strategy. The company's risk profile is further complicated by the healthcare sector's sensitivity to regulatory changes and reimbursement policies. As a provider of used medical equipment, Scandinavian Medical Solutions A/S may be affected by shifts in healthcare spending or changes in the demand for second-hand medical devices.
Key takeaways
  • Scandinavian Medical Solutions A/S has weak profitability, with a net income of 26,000 DKK and a return on equity of 0.03%.
  • The company's liquidity is moderate, with a current ratio of 1.56, but it has negative operating and free cash flows.
  • The company operates as a single business segment with no geographic diversification, increasing its exposure to regional risks.
  • Capital expenditures of -20.81 million DKK suggest ongoing investment, but without a clear path to improved profitability.
  • The risk assessment indicates medium liquidity risk and low dilution risk, but the company's financial performance could change this outlook.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyDKK
Revenue$245.4M
Gross profit$56.7M
Operating income$1.8M
Net income$26.0k
R&D
SG&A
D&A
SBC
Operating cash flow-$13.4M
CapEx-$20.8M
Free cash flow-$12.1M
Total assets$205.9M
Total liabilities$123.2M
Total equity$82.7M
Cash & equivalents$2.1M
Long-term debt$63.5M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$82.7M
Net cash-$61.4M
Current ratio1.6
Debt/Equity0.8
ROA0.0%
ROE0.0%
Cash conversion-515.9%
CapEx/Revenue-8.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Advanced Medical Equipment & Technology · cohort 3 companies
MetricSMSMEDActivity
Op margin0.7%19.4% medp25 17.8% · p75 22.0%bottom quartile
Net margin0.0%17.7% medp25 16.4% · p75 19.0%bottom quartile
Gross margin23.1%73.5% medp25 71.3% · p75 75.8%bottom quartile
R&D / revenue6.2% medp25 4.7% · p75 12.0%
CapEx / revenue-8.5%4.3% medp25 3.9% · p75 4.3%bottom quartile
Debt / equity77.0%41.5% medp25 29.2% · p75 51.3%top quartile
Observations
IR observations
Mean price target3.00 DKK
Median price target3.00 DKK
High price target3.00 DKK
Low price target3.00 DKK
Mean recommendation3.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count0.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.00 DKK
Mean revenue estimate245,000,000 DKK
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 21:46 UTC#527eeca3
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 21:47 UTCJob: a4ca3605